Trial intelligence / Profile preview

ProThio Study

2024-516072-15-00Phase 4Suspended

Sponsor
University Hospital Odense
Start
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of propofol and tiomebumal sodium (2 arms), sponsored by University Hospital Odense. Primary endpoint: Loss of eyelash reflex and acceptance of facemask. Started Jun 2022; status: suspended.

02

Drugs

propofoltiomebumal sodium

Beyond the preview

Go deeper on 2024-516072-15-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-516072-15-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call